Scientific publications

Frontiers in Immunology, 2025
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

Rodero-Romero A., Domínguez-Mozo M., Monreal E. et al.

BMJ Open, 2025
Prospective association of the triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio with anxiety risk in a community-based cohort: a UK Biobank study

Ren H., Zhao T., Lv Z. et al.

Experimental and Molecular Pathology, 2025
Persistent renin-angiotensin system and inflammatory dysregulation following COVID-19 impairs ischemic stroke recovery

Quek A., Teng O., Park J. et al.

Scientific Reports, 2025
Inflammatory response in bacteremia survivors and non-survivors: a case-control study

Ojanen M., Seiskari T., Aittoniemi J. et al.

Nature Communications, 2025
An inherited mitochondrial DNA mutation remodels inflammatory cytokine responses in macrophages and in vivo in mice

Marques E., Burr S., Casey A. et al.

Journal of Pediatric Gastroenterology and Nutrition, 2025
A set of serum proteomic biomarkers differentiates celiac children from age and human leukocyte antigen‐matched healthy controls

Mandile R., di Tolla M., Carpinelli M. et al.

European Journal of Medical Research, 2025
Proteomics identifies complement protein signatures in patients with primary biliary cholangitis

Ma X., Dong H., Han J. et al.

Ecotoxicology and Environmental Safety, 2025
Smoking elevating osteoarthritis risk: Insights from genetics, blood DNA methylations and proteome profiles

Ling D., Jiang Z., Zhou H. et al.

JHEP Reports, 2025
Plasma IGFBP7 improves risk reclassification for liver-related outcomes: insights from proteo-transcriptomic profiling

Liang Z., Jin H., Gao W. et al.

GeroScience, 2025
Glycemic status-dependent proteomic signatures of biological aging for health risk prediction

Li J., Li J., Xu X. et al.

Journal of Allergy and Clinical Immunology: Global, 2025
Inflammatory and fibrotic biomarkers in patients with atopic dermatitis treated with cendakimab

Li J., Gilvary C., Gao L. et al.

Cell Reports Medicine, 2025
L-Phenylalanine is a metabolic checkpoint of human Th2 cells

Kulkarni A., Rodriguez-Coira J., Stocker N. et al.

BMC Pulmonary Medicine, 2025
Potential drug targets for chronic obstructive pulmonary disease in the plasma proteome identified through Mendelian randomization

Jia Q., Xiao J., Zhang W. et al.

Psychoneuroendocrinology, 2025
Association of circulating immune cell phenotypes and peripheral inflammatory biomarkers with depressive symptoms in the Framingham Heart Study

Iyer S., Cao Y., Liebegott R. et al.

Blood Cancer Journal, 2025
Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance

Hsu J., Yadav U., Garapati K. et al.

Molecular Cancer, 2025
Increased plasma concentrations of acyl-coenzyme A binding protein (ACBP) predict future lung cancer development in smokers at risk of cardiovascular disease

Fidelle M., Chen H., Montégut L. et al.

BMC Oral Health, 2025
Methodological comparison between salivary and plasma inflammatory biomarkers in third molar surgery patients

Eriksson L., Larsson A., Eriksson M. et al.

Molecular Oncology, 2025
Next‐generation proteomics improves lung cancer risk prediction

Bhardwaj M., Frick C., Schöttker B. et al.

Brain, Behavior, and Immunity, 2025
Searching for blood biomarkers and treatment targets in Women with fibromyalgia – Protein interaction patterns and anti-satellite glia cell IgG antibodies as promising candidates

Ekenstam K., Menezes J., Jakobsson J. et al.

Communications Biology, 2025
Identification of causal plasma proteins and targeted therapy for primary hepatic carcinoma via proteome-wide Mendelian randomization

Wang H., Hu K., Tang C. et al.